Fifth Third Bancorp Amphastar Pharmaceuticals, Inc. Transaction History
Fifth Third Bancorp
- $28.3 Billion
- Q2 2025
A detailed history of Fifth Third Bancorp transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 480 shares of AMPH stock, worth $12,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
480
Previous 372
29.03%
Holding current value
$12,840
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.3MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$159 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$71.9 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$54.4 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$43.5 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$42.2 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.31B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...